CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Monday reported a loss of $26.2 million in its first quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 14 cents.
The kidney disease treatment developer posted revenue of $40.1 million in the period.
The company’s shares closed at $1.09. A year ago, they were trading at 38 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.